Loading...
•
Mar 31, 2021
CVS Health Q1 2021 Earnings Report
CVS Health reported strong first-quarter results, raised its full-year EPS guidance, and confirmed its cash flow from operations guidance ranges.
Key Takeaways
CVS Health announced strong Q1 results, with total revenues increasing to $69.1 billion, a 3.5% increase compared to the prior year. GAAP diluted EPS was $1.68, up 9.8% year-over-year, and adjusted EPS was $2.04, reflecting a 6.8% increase. The company generated a cash flow from operations of $2.9 billion and raised its full-year EPS guidance.
Total revenues increased to $69.1 billion, up 3.5% compared to prior year
GAAP diluted EPS of $1.68, up 9.8% compared to prior year
Adjusted EPS of $2.04, up 6.8% compared to prior year
Generated cash flow from operations of $2.9 billion
Revenue by Segment
Forward Guidance
The Company raised its full year 2021 GAAP diluted EPS guidance range to $6.24 to $6.36 from $6.06 to $6.22 and its full year 2021 Adjusted EPS guidance range to $7.56 to $7.68 from $7.39 to $7.55 and confirmed its full year 2021 cash flow from operations guidance range of $12.0 billion to $12.5 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...